Reform UK

News

Experts have pushed back against anti-vaccine comments made by an advisor to the Trump administration at the Reform UK conference.

News

Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.